Ellsworth et al. also showed that the frequency of allelic imbalance assessed by a panel of microsatellite markers representing 26 chromosomal regions was significantly higher in HER2 positive tumors than in HER2 negative tumors, suggesting global genomic instability in HER2 positive breast cancer [38]. Here, ERBB2 is linked to breast carcinoma.